Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
merck
4
×
amgen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
national
national blog main
national top stories
new york blog main
new york top stories
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's
biogen
cancer
deals
diagnostics
gene therapy
immunotherapy
president trump
What
patients
4
×
bio
drug
roundup
company
acquisitions
admi
advantages
albert
altoida
approved
augmented
bar
becker
biggest
billions
bourla
brings
ceo
chief
crispr
developing
diseases
dollars
eaton
expect
food
founder
future
gamble
gene
healthcare
identifying
illness
impact
imports
ioannis
life
maker
maps
Language
unknown
unset
Current search:
merck
×
patients
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@techcrunch.com
4 years ago
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases
